Prostate cancer detection by prebiopsy 3.0-Tesla magnetic resonance imaging

International Journal of Urology

Volumn 18, Issue 9, 2011, Pages 653-658

  Nishida, Sachiyo ^a   Kinoshita, Hidefumi ^a   Mishima, Takao ^a   Kurokawa, Hiroaki ^a   Sakaida, Noriko ^a   Matsuda, Tadashi ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

3.0 Tesla magnetic resonance imaging (MRI); Diagnostic value; Gleason score; Prostate cancer; Radical prostatectomy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER LOCALIZATION; COMPARATIVE STUDY; CONTROLLED STUDY; DIGITAL RECTAL EXAMINATION; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATECTOMY; TRANSRECTAL ULTRASONOGRAPHY; TUMOR BIOPSY;

AGED; BIOPSY; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; PROSTATECTOMY; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES;

EID: 80051869116     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2011.02814.x     Document Type: Article

References (20)

1. Ikonen S, Karkkainen P, Kivisaari L etal. Magnetic resonance imaging of clinically localized prostate cancer. J. Urol. 1998; 159: 915-19.
2. Kirkham AP, Emberton M, Allen C. How good is MRI at detecting and characterizing cancer within the prostate? Eur. Urol. 2006; 50: 1163-74.
3. Ikonen S, Kivisaari L, Tervahartiala P, Vehmas T, Taari K, Rannikko S. Prostatic MR imaging. Accuracy in differentiating cancer from other prostatic disorders. Acta Radiol. 2001; 42: 348-54.
4. Shimofusa R, Fujimoto H, Akamata H etal. Diffusion-weighted imaging of prostate cancer. J. Comput. Assist. Tomogr. 2005; 29: 149-53.
5. Lemaitre L, Puech P, Poncelet E etal. Dynamic contrast-enhanced MRI of anterior prostate cancer: morphometric assessment and correlation with radical prostatectomy findings. Eur. Radiol. 2009; 19: 470-80.
6. Villers A, Peuch P, Mouton D, Leroy X, Ballereau C, Lemaitre L. Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: correlation with radical prostatectomy findings. J. Urol. 2006; 176: 2432-7.
7. Eskew LA, Bare RL, McCullough DL. Systemic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J. Urol. 1997; 157: 199-202.
8. Babaian RJ, Toi A, Kamoi K etal. A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy. J. Urol. 2000; 163: 152-7.
9. Djavan B, Ravery V, Zlotta A etal. Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop? J. Urol. 2001; 166: 1679-83.
10. Zakian K, Sircar K, Hricak H etal. Correlation of proton MR spectroscopic imaging with Gleason score based on step-section pathologic analysis after radical prostatectomy. Radiology 2005; 234: 804-14.
11. Hom JF, Coakley FV, Simko JP etal. Prostate cancer tumor volume: measurement with endorectal MR and MR spectroscopic imaging. Radiology 2002; 223: 91-7.
12. Dhingsa R, Qayyum A, Coakley FV etal. Prostate cancer localization with endorectal MR imaging and MR spectroscopic imaging: effect of clinical data on reader accuracy. Radiology 2004; 230: 215-20.
13. Kim CK, Park BK, Han JJ etal. Diffusion-weighted imaging of the prostate at 3T for differentiation of malignant and benign tissue in transition and peripheral zones: preliminary results. J. Comput. Assist. Tomogr. 2007; 31: 449-54.
14. Park BK, Kim B, Kim CK etal. Comparison of phased-array 3.0-T endorectal 1.5-T magnetic resonance imaging on the evaluation of local staging accuracy for prostate cancer. J. Comput. Assist. Tomogr. 2007; 31: 534-8.
15. Lattouf JB, Grubb RL III, Lee SJ etal. Magnetic resonance imaging-directed transrectal ultrasonography-guided biopsies in patients at risk of prostate cancer. BJU Int. 2007; 99: 1041-6.
16. Turkbey B, Pinto PA, Mani H etal. Prostate cancer: value of multiparametric MR imaging at 3T for detection. Histopathologic correlation. Radiology 2010; 255: 89-99.
17. Ahmed HU, Kirkham A, Arya M etal. Is it time to consider a role for MRI before prostate biopsy? Nat. Rev. Clin. Oncol. 2009; 6: 197-206.
18. Nakashima J, Tanimoto A, Imai Y etal. Endorectal MRI for prediction of tumor site, tumor size, and local extension of prostate cancer. Urology 2004; 64: 101-5.
19. Yoshimitsu K, Kiyoshima K, Irie H etal. Usefulness of apparent diffusion coefficient map in diagnosing prostate carcinoma: correlation with stepwise histopathology. J. Mag. Reson. Imaging 2008; 27: 132-9.
20. International Union Against Cancer. TNM Classification of Malignant Tumours, 6th edn. Sobin LH, Wittekind Ch (eds). New York, Wiley-Liss. 2002.